Cover Image

Follow-up data of rituximab as adjuvant therapy in pemphigus

Saved in:

Bibliographic Details
Main Authors:	Uday S Khopkar (Author), Akansha Anil Chadha (Author), M S N. Nitya (Author), Vikram Lahoria (Author)
Format:	Book
Published:	Wolters Kluwer Medknow Publications, 2017-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Rituximab Therapy for Treatment of Pemphigus in Southeast Asians
by: Kanokrungsee S, et al.
Published: (2021)

Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy
by: Gabrielle Benesh, BS, et al.
Published: (2021)

Use of low-dose rituximab to treat pemphigus
by: Sandra M.B. Durães, et al.
Published: (2024)

Pediatric pemphigus herpetiformis treated with rituximab
by: Mira Hamed, MD, et al.
Published: (2024)

Quantitative estimation of antidesmoglein autoantibodies by ELISA in pemphigus patients and its correlation with disease activity
by: Seema A Korgaonkar, et al.
Published: (2021)

Rituximab in pemphigus: Road covered and challenges ahead
by: Keshavamurthy Vinay, et al.
Published: (2018)

Efficacy of rituximab in pediatric pemphigus: A literature review
by: Meera H. Patel, BS, et al.
Published: (2022)

Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil
by: Stephanie Del Rio Navarrete Biot, et al.
Published: (2014)

Off-label use of rituximab in dermatology: pemphigus treatment
by: Lislaine Bomm, et al.
Published: (2013)

Efficacy of Repeated Courses of Rituximab as Treatment for Pemphigus Vulgaris
by: Sharon Baum, et al.
Published: (2020)

Rituximab in the Management of a Child with Pemphigus Vulgaris: Case Study
by: Nikolay N. Murashkin, et al.
Published: (2022)

Hepatitis B reactivation in patients with pemphigus vulgaris after immunosuppressive therapy including rituximab
by: Dae San Yoo, MD, et al.
Published: (2020)

A modified regimen of rituximab in pemphigus: A retrospective study
by: Tanvi Pradeep Vaidya, et al.
Published: (2020)

Extragenital lichen sclerosus et atrophicus co-exististing with pemphigus vulgaris
by: Chirag Desai, et al.
Published: (2017)

Use of rituximab in the treatment of pemphigus vulgaris in a juvenile patient
by: Hanna Róża Cisoń, et al.
Published: (2024)

Rituximab therapy in a case of pemphigus vulgaris triggering herpes simplex infection at varied sites
by: Kiran K Chotaliya, et al.
Published: (2015)

Granulomatous variant of giant centrifugal miliaria profunda in a hypothyroid infant: A case report
by: Akansha A Chadha, et al.
Published: (2019)

The positive impact of rituximab on the quality of life and mental health in patients with pemphigus
by: Hanan Rashid, MD, et al.
Published: (2022)

Pregnancy outcomes in women with pemphigus exposed to rituximab before or during pregnancy
by: Azin Dehghanimahmoudabadi, MD, et al.
Published: (2022)

Successful treatment of recalcitrant juvenile pemphigus foliaceus with intravenous immunoglobulin and rituximab
by: Hock Gin Teo, et al.
Published: (2022)

Severe Pemphigus Vulgaris Resistant to Conventional Therapies and with Hypersensitivity to Rituximab in a 12-Year-Old Child
by: Maria Beatrice De Felici Del Giudice, et al.
Published: (2023)

Short-term clinical and serological follow-up with conventional and conformational anti-desmoglein antibodies in treatment-naïve and previously treated patients with pemphigus vulgaris after receiving rituximab
by: Hoorieh Alaeen, MD, et al.
Published: (2019)

Experience of rituximab therapy in pemphigus: A three-year retrospective study from a Sub-Himalayan State
by: Ghanshyam Verma, et al.
Published: (2022)

Köbner Phenomenon in a Rituximab-Treated Pemphigus Patient: Beware Disease Activity
by: Soheil Tavakolpour, et al.
Published: (2019)

Crusted scabies in a patient with pemphigus vulgaris after treatment with rituximab and corticosteroids
by: Sepideh Ashrafzadeh, BS, et al.
Published: (2020)

Use of rituximab in pemphigus vulgaris/foliaceus patients during COVID-19 pandemic
by: Inês Aparício-Martins, et al.
Published: (2022)

Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris
by: Katharina Boch, et al.
Published: (2022)

Severe Multi-Resistant Pemphigus vulgaris: prolonged remission with a single cycle of Rituximab
by: Isabela Soubhia Corral, et al.
Published: (2013)

The efficacy and safety of low-dose rituximab in the treatment of pemphigus vulgaris: a cohort study
by: Xingli Zhou, et al.
Published: (2024)

Venous thromboembolism in a case with pemphigus vulgaris after infusion of rituximab plus systemic glucocorticoids and azathioprine: A possible adverse effect of rituximab?
by: Kuan-Jou Wu, et al.
Published: (2021)

Management of pemphigus vulgaris with rituximab: A case report and brief review on emerging treatment options
by: Massillamani Francis, et al.
Published: (2019)

Pulse therapy in pemphigus: Ready reckoner
by: Anil Abraham, et al.
Published: (2016)

Pulse Therapy in Rituximab Era: A Retrospective Study of 124 Patients of Pemphigus from a Tertiary Care Center of South Rajasthan
by: Asit Mittal, et al.
Published: (2024)

Cotrimoxazole as a Preventative Intervention for Pneumocystis Pneumonia in Pemphigus Patients Treated with Rituximab: A Retrospective Study
by: Hao-Chen Hsu, et al.
Published: (2023)

Targeted Immunotherapy with Rituximab Leads to a Transient Alteration of the IgG Autoantibody Profile in Pemphigus Vulgaris
by: Ralf Müller, et al.
Published: (2010)

Survival of Adjuvant Drugs for Treatment of Pemphigus: A Population-based Cohort Study
by: Khalaf Kridin, et al.
Published: (2021)

A comparative study to evaluate the efficacy and cost of rituximab versus dexamethasone cyclophosphamide pulse in patients of pemphigus vulgaris
by: Sudip Das, et al.
Published: (2021)

Indirect immunofluorescence on rat bladder epithelium in patients with pemphigus vulgaris with an extended follow‐up
by: Mahsa Samadi, et al.
Published: (2022)

Sustained CD19+CD27+ Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus Vulgaris
by: Katharina Boch, et al.
Published: (2022)

Pemphigus vulgaris aggravated by obsessive-compulsive behavior: the importance of adjuvant topical occlusive dressing
by: Paula Basso Lima, et al.
Published: (2021)